Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.
Biomarkers Market (Diagnostic Applications in Risk Assessment, Molecular Diagnostics,
Disease Diagnosis, Drug Discovery & ...
Description
Biomarkers are novel diagnostic tools that provide intelligence to physician
about disease progression and tre...
Overview
Disease diagnostic application remains the key area of application that is
expected to reach 6.1 $billion in 2020...
Key Benefits
• Assessment and ranking the factors that favor the market growth and those
factors which act as a hindrance ...
Key Audiences
• Pharmaceutical companies
• Government & Private research institutes
• Academic institutes
• Medical device...
Biomarkers in Top Technologies
• Lengthy Process
• Ethical Problems
• Gene Expression
Omics Technology
• Radiation Effect
...
Top Factors Impacting DBM Market
• Non-Invasive Technique
• Drug Discovery and Development
• Cost Effective Tool for Diagn...
Market Dynamics Drivers
• Cost Effective
• Non-Invasive
• Accuracy in Result
• Assistant in Clinical Trials
• Multi-Marker...
Diagnostic Biomarker Market By Services
Assay Development
• Complexity in Technique
• Tissue Specific
Biomarker Validation...
Companies
• Abbott Laboratories, Inc.
• Agilent Technologies Inc.
• Aushon Biosystem
• Bio-Rad Laboratories
• Eisai Co. Lt...
Market By Geography
Get full access of report at:
http://www.analyzefuture.com/biomarkers-market
Upcoming SlideShare
Loading in …5
×

Biomarkers Market (Diagnostic Applications in Risk Assessment, Molecular Diagnostics, Disease Diagnosis, Drug Discovery & Development, Drug Formulation, Forensic Applications and Others)

653 views

Published on

Biomarkers are novel diagnostic tools that provide intelligence to physician about disease progression and treatment effects. Advancement in understanding of human genome promotes its application in diagnosis of disease on molecular basis. Biomarker technology is evidencing increased application in disease diagnosis, drug development and formulation, diagnosis for exposure of certain harmful chemical and prognostic treatments.

  • Be the first to comment

  • Be the first to like this

Biomarkers Market (Diagnostic Applications in Risk Assessment, Molecular Diagnostics, Disease Diagnosis, Drug Discovery & Development, Drug Formulation, Forensic Applications and Others)

  1. 1. Biomarkers Market (Diagnostic Applications in Risk Assessment, Molecular Diagnostics, Disease Diagnosis, Drug Discovery & Development, Drug Formulation, Forensic Applications and Others) - Global Industry Analysis, Emerging Technologies, Competitive Intelligence, Growth Trends, Size, Share, Opportunities and Forecast, 2013 - 2020 Biomarkers Market Published : 10-Dec-2013 Pages: 151
  2. 2. Description Biomarkers are novel diagnostic tools that provide intelligence to physician about disease progression and treatment effects. Advancement in understanding of human genome promotes its application in diagnosis of disease on molecular basis. Biomarker technology is evidencing increased application in disease diagnosis, drug development and formulation, diagnosis for exposure of certain harmful chemical and prognostic treatments. The global market for diagnostic biomarker is expected to reach about $30.6 billion in 2020, growing at CAGR of 16% from 2013 to 2020. Pharmaceutical companies, which are interested in introducing novel diagnostic solution are increasing partnership and collaboration with private laboratories, and educational institutes. The companies are also increasing their investments in research and development.
  3. 3. Overview Disease diagnostic application remains the key area of application that is expected to reach 6.1 $billion in 2020. However, application of diagnostic biomarkers in forensics and molecular diagnostics is catching up quite significantly. Molecular diagnostics is expected to grow at a CAGR of 17.6% from 2013 to 2020.
  4. 4. Key Benefits • Assessment and ranking the factors that favor the market growth and those factors which act as a hindrance for the growth of the market • The market sizing and estimation period is from 2013 to 2020. Two historic years include 2011 and 2012 • The report identifies and analyses top investment pockets and top winning strategies for diagnostic biomarker market • The report analyses the various strategies adopted by some of the key companies in the market • The report tracks and analyses key innovations and patents for biomarkers in the last five years
  5. 5. Key Audiences • Pharmaceutical companies • Government & Private research institutes • Academic institutes • Medical device manufacturing companies
  6. 6. Biomarkers in Top Technologies • Lengthy Process • Ethical Problems • Gene Expression Omics Technology • Radiation Effect • Complex Process • Genetic Variation Imaging Technology • Difficulty in Practical Application • Over-Fitting • Costly Management Bioinformatics
  7. 7. Top Factors Impacting DBM Market • Non-Invasive Technique • Drug Discovery and Development • Cost Effective Tool for Diagnosis • Multi-Marker Application • Accuracy and Reliability • Ethical Issues • Gene Level Diagnosis • Complex Processes • Government Regulations
  8. 8. Market Dynamics Drivers • Cost Effective • Non-Invasive • Accuracy in Result • Assistant in Clinical Trials • Multi-Marker Application • Gene Level Diagnosis
  9. 9. Diagnostic Biomarker Market By Services Assay Development • Complexity in Technique • Tissue Specific Biomarker Validation and Testing • Clinical Errors • Time Consuming
  10. 10. Companies • Abbott Laboratories, Inc. • Agilent Technologies Inc. • Aushon Biosystem • Bio-Rad Laboratories • Eisai Co. Ltd. • Epistem Ltd. • Ge Healthcare • Roche Diagnostics Limited
  11. 11. Market By Geography
  12. 12. Get full access of report at: http://www.analyzefuture.com/biomarkers-market

×